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ABSTRAK 
Tarigan S, Sumarningsih. 2019. Pembuatan antibodi monoklonal-scFV untuk Uji Diagnostik Avian Influenza. JITV 24(1): 29-
38. DOI: http://dx.doi.org/10.14334/jitv.v24i1.1871 
Kebutuhan alat diagnostik cepat atau point-of-care diagnostic test untuk penyakit Avian Influenza di Indonesia sangat besar. 
Sampai saat ini alat diagnostik tersebut diimpor sehingga harganya mahal. Akibatnya, pengadaannya membutuhkan anggaran 
yang besar. Komponen utama alat diagnostik cepat adalah antibodi monoklonal yang spesifik terhadap virus influenza. 
Penelitian ini bertujuan memproduksi mAb yang bisa mengenali semua subtipe Avian Influenza menggunakan teknologi phage 
display. Influenza-A focused scFv library komersial di panning menggunakan rekombinan NP H1N1 dan virion H5N1 secara 
bergantian. Sedangkan bakteriofag yang terikat pada antigen panning dielusi dengan serum dari ayam yang memiliki antibodi 
terhadap virus H5N1. Phagemid dari suppressor E. coli (TG1) yang terinfeksi bakteriofag yang menampilkan anti-NP pada 
permukaanya diisolasi lalu ditransformasikan pada non-supressor E. coli (HB2151) untuk mengekspresikan NP-scFv. Antibodi 
monoklonal NP-scFv dengan berat molekul sekitar 27 kDa dipurifikasi dari supernatan biakan menggunakan kolom 
kromatografi nikel. Jumlah NP-scFv murni yang diperoleh adalah sekitar 1.2 mg/L biakan. Sebagai komponen tambahan untuk 
penggunaanya dalam immunoassay, antibodi terhadap NP-scFv diproduksi pada kelinci. Antibodi poliklonal yang dihasilkan 
mengenali NP-scFv dengan spesifik dan sensitif. Antibodi monoklonal anti-NP-scFv dan poliklonal anti scFv yang dihasilkan 
dalam penelitian ini dapat digunakan untuk pengembangan alat diagnostik point -of- care Avian Influenza. 
Kata Kunci: Avian Influenza, Nukleoprotein, Antibodi scFv, Alternating Panning, Uji POC 
ABSTRACT 
Tarigan S, Sumarningsih. 2019. Generation of scFv-monoclonal antibody Avian Influenza Diagnostic Tests. JITV 24(1): 29-38. 
DOI: http://dx.doi.org/10.14334/jitv.v24i1.1871 
The need for rapid diagnostic tools or point- of- care diagnostic tests for Avian Influenza in Indonesia is very high and the 
price of these imported diagnostic tools is very expensive. As a result, a large budget requires to provide the needs. The main 
component of a rapid diagnostic tool is the monoclonal antibody (mAb) specifically recognized influenza viruses. The objective 
of this study was to produce mAb that can recognize all subtypes of Avian Influenza viruses using the phage display technology. 
Influenza-A focused scFv commercial library was panned using alternating recombinant H1N1 NP and H5N1 virions. Whereas, 
bacteriophages bound to the panning baits were eluted with serum from H5N1-infected chickens. Phagemid from suppressor E. 
coli (TG1) infected with bacteriophage displaying anti-NP on its surface was isolated and then transformed into a non-suppressor 
E. coli (HB2151) to express NP-scFv. Monoclonal NP-scFv antibody with a molecular weight of about 27 kDa was purified 
from the culture supernatant using a nickel-chromatography column. The amount of pure NP-scFv obtained was around 1.2 mg 
/L culture. As an additional component for its use in immunoassays, antibody to NP-scFv was produced in rabbits. The 
generating polyclonal antibody recognized the NP-scFv specifically and sensitively. The anti-NP-scFv monoclonal antibody and 
the anti rabbit scFv polyclonal antibody produced in this study are envisaged appropriate for the development of diagnostic tools 
for point-of-care for Avian Influenza. 
Key words: Avian Influenza, Nucleoprotein, scFv Antibody, Alternating Panning, POC Test 
INTRODUCTION 
The H5N1 avian influenza seems to be one of the 
most devastating zoonotic diseases ever known to date 
(FAO 2013). One of the main factors causing the rapid, 
wide spread of the disease was the delay in diagnosis 
and implementing actions to eradicate the disease. 
Diagnosis of infectious diseases that spread rapidly 
such as AI H5N1 requires the availability of rapid or 
point-of -care diagnostic (POC) tools. Most of the POC 
diagnostic tools for Influenza both for human and 
poultry are based on monoclonal antibody specific 
against the nucleoprotein of the type A Influenza virus 
(Tarigan 2016). The main advantages of using 
monoclonal include batch-to-batch homogeneity and 
excellent specificity. Polyclonal antibodies are much 
easier, cheaper and faster to produce but the variability 
between different batches produced in different animals 
at different times is unavoidable. In addition, since 
polyclonal antibody comprises huge number of 
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antibodies recognizing different epitopes, cross-reaction 
is inescapable (Liu 2014; Shalit et al. 1985). 
Two approaches to produce monoclonal antibodies 
are currently available. The first approach was the 
hybridoma technology introduced by Kohler and 
Milstein (Kohler & Milstein 1975). This approach 
involves fusion of B-cells from immunized donor 
animal with myeloma cell to generate immortal cells 
producing monoclonal antibody. Some drawbacks of 
this approach include the use of animals and the limited 
species of animal as the source of antibody that can be 
used. So far, myeloma cells that available for that 
purpose are only mouse and rat origin (Liu 2014).  
The second approach for production of monoclonal 
antibody is the phage display technology introduced in 
the late 20
th
 century (Smith & Petrenko 1997). Briefly, 
the approach began by isolation of mRNA from B-
lymphocites from donor animals or human, either naïve 
or immune to a relevant antigen. The heavy variable 
(VH) and light variable (VL) segments are amplified 
and connected with a short linker with PCR then batch-
cloned into a special phagemid vector, next to the pIII 
protein of filamentous bacteriophage. A competent E. 
coli strain is transformed with the phagemid and is 
rescued with a helper phage to derive a single chain 
variable fragment (scFv)-phage library. Each phage in 
the library recognizes different epitope through the scFv 
that fused to the bacteriophage surface protein PIII. The 
diversity of a scFv library is usually in the range of 
millions to trillions. The next most important step is to 
select and purify scFv-phages that recognize the desired 
antigen by the protocol known as panning. Phagemids 
from the E. coli harboring scFv phage are isolated and 
transformed into competent cells of a non-suppressor 
strain of E. coli in order to express the scFv antibody 
(Clackson et al. 1991; Hoogenboom et al. 1998).  
Production of mAb using the phage display 
approach offers many benefits. Once a library is made 
or purchase commercially, the same library can be used 
to generate many different mAbs. The production does 
not require the use of animal. Unlike maintaining 
hybridoma, which requires liquid nitrogen; maintaining 
and storage of E. coli, phagemid and bacteriophage for 
future mAb production are easy. The molecule of 
phage-display mAb is ease to modify; such tagging with 
other peptides or increase its affinity through an affinity 
maturation process. The phage-display mAbs penetrate 
tissue more easily because of its small molecular size 
(Liu 2014; Nissim et al. 1994; Thompson et al. 1996). 
The aim of the present study was to produce mAb 
recognizing a common antigen for type-A- influenza 
viruses, the nucleoprotein, using the phage display 
technology. The mAb is envisaged suitable as the main 
component of POC test for influenza in animals and 
human. 
MATERIALS AND METHODS 
Library and E. coli strain 
Ready-to-panning H1N1 library (human scFv) was 
obtained from Oak Bioscience, Sunnyvale, CA (USA). 
This H1N1-focused library, which was developed from 
human B-cells, had a diversity of 10
5 
and a titer of 10
11
 
plaque forming unit (pfu)/ml. Helper phage (M13O7) 
and E. coli TG1 (K-12 glnV44 thi-1 Δ(lac-
proAB) Δ(mcrB-hsdSM)5(rK
–
mK
–) F′ 
[traD36 proAB
+
 lacI
q
 lacZΔM15] ) and HB2151 E. coli 
(K12 (lac-pro), ara, nalr, thi/F'[proAB, lacIq, lacZ M15] 
from Creative Biolab, Shirley, NY, USA.  Recombinant 
nucleoprotein H1N1 Influenza virus (NP), anti-M13 
monoclonal antibody (Sino Biological, China), and anti-
H5N1 serum was obtained from chicken that had been 
vaccinated and infected with life H5N1 virus in our 
previous study (Tarigan et al. 2015). The H5N1 sub-
type influenza virus was an Indonesian isolate, 
previously isolated from chicken (Tarigan et al. 2015). 
Delipidation of H5N1 virion 
The purpose of removing lipid from the H5N1 
virion is to increase the binding capacity of viral 
proteins to polystyrene immunotube or plate. 
Delipidation was carried out according to a previous 
method (Cham & Knowles 1976). Briefly, virus 
suspension in PBS (10
7
 EID50/ml) was mixed with 2 
volumes of butanol and di-iso prophyl ether mixture 
(40% : 60%). After shaking for 60 min, the mixture was 
centrifuged (1000 x G, 10 min) and the organic phase 
was discarded. An equal amount of ethyl ether was 
added to the aqueous phase, shaking and centrifuged as 
previously. This ethyl-ether treatment was repeated in 
order to remove residual butanol. Finally, the 
delipidated virion suspension was aliquoted and freeze-
dried. 
Panning 
Two immune tubes were coated at 4ºC overnight 
with NP (2 µg in 1 ml) and delipid H5N1 virus (10
7
 in 1 
ml carbonate buffer, pH 9.6), respectively. After 
washing 4 times with PBST (PBS plus 0.05% Tween-
20) and blocking with 1% bovine serum albumin (BSA) 
for 2 hr, 1 ml H1N1 library containing 10
11 
pfu in 1 ml 
PBS was added and incubated for 2 hr at 37ºC. After 
removing unbound phages by washing 10 times with 
sterile PBST and twice with PBS, 1 ml chicken-anti-
H5N1 serum (diluted 1: 50 in 2YT broth) was added, 
incubated at 37ºC for 30 min with 250 rpm shaking to 
release phages bound to NP or H5N1. 
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The eluted phage suspension was filtered (0.2 µm 
pore) and added to 9 ml log-phase TG1-E. coli. After 
incubation stationarily at 37ºC for 30 min, 20 ml 2YT 
broth containing 2% glucose and 150 µg/ml carbencillin 
were added and incubated at 37ºC, 250 rpm shaking 
until mid-log phase (A600 = 0.5). Helper phage 2.4 x 
10
11
 pfu were added and incubated stationarily at 37ºC 
for 30 min. After the incubation, the bacterial cells were 
pelleted and suspended in 2YT medium containing 100 
µg carbencilin/ml and kanamycin 50 µg/ml. After 
incubation overnight at 37ºC, 250 rpm shaking, the 
bacterial cells were pelleted; the supernatant was 
removed and filtered with 0.45-µm filter. A one-fifths 
volume of PEG-NaCl (20% polyethylene glycol 8000 in 
2.5 M NaCl) was added to the supernatant, left at 4ºC 
for at least 30 min, and then centrifuged (7000 x G, 30 
min). The pelleted phages were suspended in PBS 
containing 20% glycerol, aliquoted and stored at -70ºC 
until used.  
The second round of panning was carried out 
similarly, except that both collection of phages, i.e 
phages with NP and those with H5N1 baits in the first 
panning, were each panned with NP and H5N1 baits. 
Four different collections of phages were produced: 
NP-NP, NP-H5N1, H5N1-H5N1 and H5N1-NP, 
identified with the first and second baits. In the third 
round of panning, the four collections of phages were 
panned against NP, and phages bound to NP were 
eluted with 0.1 M glycine-HCl pH 2. A mid-log phase 
TG1 E. coli culture was infected with each of the eluted 
phages and plated on 2YT agar containing 100 µg/ml 
carbencillin and 2% glucose. Individual colony, 10 – 15 
colonies per collection of phages, was picked up 
randomly and grown on 2 ml 2YT medium. At mid-log 
phase, the scFv phages were rescued with helper phage. 
The reactivity of scFv-phages was determined with a 
phage ELISA. 
Phage ELISA 
A 96-well plate (maxisorp, Nunc Inc.) was coated 
with 50 ng/well NP at 4ºC overnight. After 2-hr 
blocking with 2% BSA, the third panned phages were 
added, approximately 10
11
 pfu/ well, and incubated at 
37ºC, 250 rpm for 2 hr. After 5 times washings with 
PBST, rabbit anti M13O7 phage, diluted 1 : 2000 in PBS 
containing 5% normal chicken serum was added, and 
incubated at 37ºC, 250 rpm for 2 hr. After 5 times 
washings with PBST, substrate and ABTS were added 
and optical density (A420) were measured.  
Phagemids were isolated from TG1 E. coli 
containing the strongest reactivity of phages using a 
commercial kit (QIAprep mini prep kit, Qiagen).  The 
isolated phagemid were kept at -20ºC until use. 
Transformation and clone selection 
The competent cells were prepared according to a 
previous methods (CHUNG et al. 1989). Briefly, 
HB2151 E. coli, at early log-phase in LB broth (A600 = 
0.35) was pelleted (1000 x G, 10 min). The pellet was 
suspended in transformation solution (10% 
polyethylene glycol 8000, 5% DMSO and 50 mM 
MgCl2), one-tenth of its original volume). The cell 
suspension was aliquoted in 100 µl tube and kept in -
80ºC until used. 
For transformation, 1 ng or 0.1 ng phagemid in 1 µl 
volume was added to the 100 µl competent cells and 
incubated at 4ºC for 30 min. After adding 0.9 ml LB 
broth, the suspension was incubated at 37ºC, 250 rpm 
for 1 hr, then plated in LB agar containing 100 µg/ml 
carbencillin. After incubation overnight at 37ºC, 
individual colony, selected randomly, was touched 
lightly with a toothpick and suspended in 0.5 ml 2YT 
broth containing 100 µg/ml carbencillin and 2% 
glucose. For scFv expression, 10 µl of the bacterial 
suspension is added to fresh 2YT broth containing 100 
µg/ml carbencillin and 0.5 % glucose (2YT-carb-glu) and 
incubated at 37ºC, 250 rpm. At mid-log phase growth 
(A600 = 0.5), 0.1 mM IPTG was added and the cultures 
were incubated at 30ºC, 250 rpm. Following overnight 
incubation, the bacterial cells were pelleted, and 100 µL 
supernatant was added to a 96-well micro-titration plate 
that had been coated previously with 20 ng NP/ well. 
After 2 hr incubation, the plate was washed 5 times 
with PBST, 100 µl anti-human 2Fab (Abcam) diluted 1: 
100 was added and incubated 2 hr. After washing 5 
times, substrate and ABTS was added, and OD was 
measured after 15 and 30 minutes. Clones producing 
the highest OD were selected for further production of 
NP-specific scFv. 
Expression and purification of scFv 
Selected transformed E. coli were grown in 2YT-
carb-glu to mid-log phase, and incubated overnight at 
30ºC after induction with 0.1 mM IPTG. The bacterial 
cells were pelleted (8000 x G, 4ºC, 20 min) and the 
supernatant was removed. Purification of scFv was 
carried out using a nickel column chromatography 
(HisTrap HP, GE Healthcare life science) on a 
chromatographic purification system, Acta start (GE 
Healthcare life science). The eluted proteins from the 
column were desalted and concentrated using a 10-kDa-
cut-off centriprep (Amicon). The purity was checked 
with a routine sodium dodecyl sulphate- polyacrylamide 
gel electrophoresis (SDS PAGE). 
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The scFv antibody and reactivity of scFv against 
nucleoprotein and H5N1 virus 
Rabbits were immunized with 1 mg of the purified 
NP-scFv intramuscularly using Quil A as adjuvant. 
Booster immunizations were given in a 4 weeks 
interval. Immune response was monitored using an 
ELISA with purified scFv as the coating antigen. Two 
weeks after the last immunization, the rabbits were 
anaesthetized and bled to death. The sera were 
aliquoted and stored at -20ºC. 
An ELISA and dot blot were used to analyze 
reactivity of scFv against NP or delipidated H5N1. The 
plate was coated with NP (20 ng/well) or delipidated 
H5N1 (≈ 200 EID50/ well). After blocking with 1 % 
BSA, purified scFv was added and incubated for 2 hr. 
After washing 5 times with PBST, the rabbit-anti-scFv 
at 1: 500 dilution was added and incubated 2hr. After 
washing 5 times with PBST, substrate and ABTS were 
added, and optical density was measured after 15 min.  
For dot-blot assay, 3 µl suspension containing either 
30 ng NP or 100 EID50 delipidated H5N1 virus were 
spotted onto a nitrocellulose strip. After blocking with 
1% BSA, purified scFv was added and incubated for 2 
hr. After washing 5 times with PBST, rabbit-anti-scFv 
serum at 1: 500 dilution was added and incubated 2hr. 
After washing 5 times with PBST, the membrane strip 
was developed in substrate and chromogenic 3’-
diaminobenzidine (DAB). 
RESULTS AND DISCUSSION 
The present study successfully isolated scFv 
monoclonal antibody that recognized recombinant NP 
from influenza H1N1 and H5N1 influenza virion. The 
capacity of recognizing both influenza-virus subtypes is 
attributed to the panning strategy used in this study, 
which is alternating NP and H5N1 as baits, and elution 
of bound phages with anti-H5N1 serum.  
Delipidation of H5N1 virion, as carried out in this 
study, was supposed to increase its immobilization on 
the polystyrene surface of the immunotube and plate. 
Tight binding of the virion to the immunotube was 
necessary to withstand intensive (12 times) washings 
during the panning process. Previously, when NP was 
used as bait singly or as the only bait, the isolated scFv 
recognized the NP but not H5N1 virion. As far as we 
were aware, this panning approach together with the 
elution with the anti-serum had not been used 
previously. 
After the first panning, the reactivity of phage to NP 
was still unapparent (Figure 1). The reactivity was 
similar to that of the control, M13O7 helper phage. 
After the second panning, either the first with NP and 
the second with NP or H5N1 virus, or the first with 
H5N1 virus and the second with NP, however, the 
reactivity increased impressively. For unknown reason, 
however, the reactivity of the phage after panning twice 
with H5N1 virus remained undetected. Reactivity of 
phage after the third panning on NP is presented on 
Table 1. The phages, which were rescued from 
randomly selected colonies of TG1 E. coli, had 
comparable reactivity. The reactivity, as expressed in 
ELISA OD’s, were about 4 times as higher as that of 
M13O7 helper phage control. 
For the production of soluble anti-scFv antibody, the 
phagemid from the suppressive TG1 E. coli was 
isolated and expressed in a suppressive E. coli strain, 
HB2151. Only in this non-suppressive strain does the 
amber stop codon (TAG), which placed as the last 
codon of scFv, function as a proper stop codon.  
Considerable amount of phagemid, 7.8 and 3.8 µg, 
respectively, was isolated from two colonies of TG1-E. 
coli harboring phage with high reactivity to the NP. 
When competent HB2151 E. coli cells were 
transformed with the NP-scFv-phagemid, they produced 
a high number of colonies on carbencillin-LB-agar 
plates due to the presence amphicilin-resistant gene in 
the phagemid. Ninety colonies were randomly selected 
and the capacity of each colony to expressed scFv 
recognizing NP is presented in Table 2. One colony 
(#47) expressing scFv with the highest reactivity was 
chosen for further scFv purification.  
In E. coli proteins are synthesized in the cytoplasm, 
some of which, however, may be translocated into the 
periplasmic compartment, and proteins accumulated in 
the periplasmic compartment may, in turn, leak out into 
the culture medium (Kipriyanov et al. 1997). The 
amount of proteins leaking into the medium depend on 
the primary structure or amino acid sequence of the 
protein, stability of membrane, composition of the 
media and duration of incubation (  c lund 2008). In 
regard to protein purification, purification of expressed 
protein from the culture media is easier than that from 
the periplasmic or cytoplasmic spaces 
In addition to the antibiotic resistance gene, the 
phagemid used in this study also equipped with the 
ompA leader sequence, which translocated the newly 
synthesized scFv from cytoplasm to the periplasmic 
compartment where the disulphide bonds stabilizing the 
molecule were formed. Also, to ease protein 
purification, the phagemid was equipped with a DNA 
sequence encoding poly histidin as a tag at the C- 
terminal of the scFv protein. 
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Figure 1. Reactivity of phages to NP or H5N1 after the first or second panning. The symbol NP or H5N1 on the x-axis denotes the 
bait used in the panning. Two codes separated by a comma, eg. NP, H5N1, represent baits used in the first and second 
panning, respectively. The symbol “Helper” represents M13O7 helper phage used as a control.  
Table 1. Reactivity of phage after the third panning on NP bait, propagated and rescued from randomly selected colonies of TG1 
E. coli 
Phage H5N1-NP Phage NP-NP Phage NP-H5N1 Helper phage 
Colony ELISA OD Colony ELISA OD Colony ELISA OD ELISA OD 
5A 1.4165 6A 1.5435 7A 1.6195 0.413 
5B* 1.347 6B 0.913 7B 1.5595 
5C* 1.636 6C 1.3795 7C 1.337  
5D 1.585 6D 1.0225 7D 1.461  
5E 1.3265 6E 1.5665 7E 1.384  
5F 1.5985 6F 1.512 7F 1.453  
5G 1.666 6G 1.616 7G 1.479  
5H 1.565 6H 1.5535 7H 1.471  
5I 1.6155 6I 1.429 7I 1.492  
5J 1.326 6J 1.1265 7J 1.181  
5K 1.5345 6K 1.4365    
5L 1.647 6L 1.491    
5M 1.5515 6M 1.439    
5N 1.3115 6N 1.474    
5O 1.5675 6O 1.4735    
(*) colonies from which phagemid was isolated and used to transform competent HB2151 E. coli 
 
Panned phage 
ELISA 
OD 
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Table 2. Reactivity of supernatants from randomly selected 90 colonies of HB2151 E.coli transformed with phagemid that had 
undergone thrice panning with NP and H5N1 virus (colonies# 5B and 5C, Table 1) 
Col # OD Col # OD Col # OD Col # OD Col # OD Col # OD 
1 0.408 16 0.394 31 0.372 46 0.363 61 0.361 76 0.384 
2 0.427 17 0.457 32 0.41 47* 0.604 62 0.32 77 0.364 
3 0.366 18 0.391 33 0.428 48 0.424 63 0.37 78 0.376 
4 0.356 19 0.361 34 0.389 49* 0.451 64 0.397 79 0.381 
5 0.34 20 0.371 35 0.355 50 0.431 65 0.411 80 0.484 
6 0.349 21 0.371 36 0.349 51 0.408 66 0.378 81 0.418 
7 0.383 22 0.364 37 0.365 52 0.392 67 0.359 82 0.392 
8 0.398 23 0.395 38 0.376 53 0.347 68 0.37 83 0.331 
9 0.387 24 0.418 39 0.375 54 0.34 69 0.377 84 0.366 
10 0.39 25 0.396 40 0.401 55 0.374 70 0.331 85 0.358 
11 0.354 26 0.368 41 0.428 56 0.412 71 0.369 86 0.372 
12 0.36 27 0.351 42 0.38 57 0.396 72 0.363 87 0.364 
13 0.374 28 0.307 43 0.36 58 0.355 73 0.391 88 0.37 
14 0.386 29 0.353 44 0.381 59 0.356 74 0.395 89 0.43 
15 0.38 30 0.359 45 0.372 60 0.327 75 0.375 90 0.42 
 
Expression of anti-NP scFv antibody in the present 
study revealed that the amount of scFv recovered from 
culture supernatant was larger than that from 
periplasmic compartment. Based on SDS PAGE, the 
major protein eluted from the nickel-ion-affinity 
chromatography had a molecular weight of about 27 
kDa, similar to that of expected scFv (Figure 2). This 
protein was highly immunogenic, as a high titre against 
the NP-scFv was obtained after the fifth immunization 
of rabbits. At 1: 1600 dilutions, the antiserum 
recognized the scFv coated on micro titre plate at a 
concentration of 44 ng/ml. At lower dilutions (1 : 200), 
it recognized at a concentration of 5 ng/ml.  
The purified scFv proved to recognized NP and 
H5N1 both in dot blot and ELISA (Figure 3 and 4). In 
dot blot experiment, the bindings of scFv to NP and to 
H5N1 virion were probed by the rabbit anti scFv serum. 
This experiment also proved the specificity of the 
antibody, as no signal was observed when the binding 
was probed with normal or pre-vaccinated serum 
(Figure 3). Results of this dot blot experiment were in 
agreement with those of ELISA. The rabbit anti-scFv 
serum affirmed the binding of purified scFv to NP or to 
H5N1 virion. The binding scFv to NP or scFv to H5N1 
that was probed with the rabbit anti-scFv serum 
prompted ELISA ODs that were about five times higher 
than those probed with negative serum. The binding 
scFv to NP or scFv to H5N1 that was probed with the 
rabbit anti-scFv serum produced ELISA ODs that were 
about five times higher than that probed with negative 
serum. Non-specific bindings between the negative 
serum with scFv, NP or H5N1 were negligible. For 
unknown reason, however, there was some non-specific 
binding between the anti-scFv serum with NP or H5N1 
(Figure 4). 
Comparable approach to the present study had been 
used by previous studies in an attempt to isolate scFv 
recognizing parvalbumin allergen from various species 
of fish (Bublin et al. 2015). For that purpose, the group 
carried out three sequential panning on cod, carp and 
rainbow-trout parvalbumins, respectively. 
One of the most common problems in scFv 
production is the low yield of functional scFv that can 
be purified from the prokaryotic expression system. The 
causes of the problem include inhibition of culture 
growth by toxic effect of the expressed scFv, formation 
of insoluble aggregates in the periplasmic compartment, 
and plasmid instability (Mergulhao et al. 2005; 
Rippmann et al. 1998). To be functional, a scFv 
required a post-translational processing, that is the 
formation of disulphide bridges (Montoliu-Gaya et al. 
2017; Ramm et al. 1999). Formation of disulphide 
bonds in prokaryotic cells is taken place only in the 
periplasmic compartment because only in this 
compartment the oxidative environment and required 
enzymes are available (Eser et al. 2009; Makrides 
1996).  
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Figure 2. A: Purification scFv from culture supernatant of HB2151 E. coli transformed with anti-NP phagemid. Culture supernatant 
was loading into a 5-ml-affinity column (HisTrap HP®) (1), unbound proteins were washed off from the column (2), bound 
protein (scFv) was eluted with imidazole solution (3).  
 B: Coomasie-blue stained SDS PAGE of protein eluted from affinity column after desalting and concentration. The elution  
contains a single protein with a ≈ 27 Da size, similar to that of scFv (red arrow). 
 
Figure 3. Reactivity of scFv against H1N1 nucleoprotein (NP) and H5N1 virion by dot blot. The NP (1 µg) or delipidated H5N1 
(≈100 EID50) is spotted onto nitrocellulose strips, the NP-scFv was added and probed with rabbit anti-scFv serum (post-vac 
serum), normal rabbit serum (pre-vac serum) or PBS (control).  
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Figure 4. Reactivity of scFv against H1N1 nucleoprotein (NP) (A) and against H5N1 virion (B) by ELISA. Micro-titer plate wells 
coated with NP, H5N1 or PBS (control) were added either scFv or PBS (control). After washings, rabbit anti-NP-scFv 
serum (post-vac serum), normal rabbit serum (pre-vac serum) or PBS (control) were added.  
 
Although the functional scFv accumulated in the 
periplasmic space, some of them may leak out into the 
culture medium (Kipriyanov et al. 1997). In this study, 
the amount of scFv purified from the culture medium 
was found to be higher than that from the periplasmic 
compartment isolated by the cold osmotic shock 
method (Neu & Heppel 1965). For this reason, isolation 
of scFv was only carried out from this compartment. In 
addition, isolation of proteins from the culture medium 
is easier that that from periplasmic compartment 
(Kipriyanov et al. 1997). 
In the present study, about 1.2 mg of anti-NP-scFv 
antibody per litre culture was obtained. This yield is 
considered to be high as compared to previous studies; 
0.59 mg/L (Mesgari-Shadi & Sarrafzadeh 2017) or 0.1 
mg/L (Kipriyanov et al. 1997). Eukaryotic cells are 
apparently more efficient than prokaryotic cells in 
expressing functional scFv. An expression of scFv in 
mammalian HEK293T cells was reported to obtain a 
yield of 12.87 to 33.56 mg/L culture (Pipattanaboon et 
al. 2017). Yeast (Pichia pastoris) expression system 
was reported to obtain even higher yield, 100 mg/L of 
pure and functional rabbit anti-rhLIF scFv antibody 
(Ridder et al. 1995). 
Various attempts to increase scFv yields in 
prokaryotic expression system have been made. 
Kipriyanov and group reported that addition of sucrose 
to the medium resulted in the yield of 16.5 mg/L scFv 
or 80- 150 fold higher than that without sucrose 
addition (Kipriyanov et al. 1997). Similar results were 
also obtained by others (Mesgari-Shadi & Sarrafzadeh 
2017; Sawyer et al. 1994). In our study, however, no 
increase in the yield was observed when sucrose was 
added to the culture media. This means that addition of 
sucrose to the culture does not always increase the 
functional scFv yield. As a matter of fact, Sina and 
group reported that addition of sucrose to the culture 
media even suppressed the expression of scFv (Sina et 
al. 2015). The cause of the differences in the response 
to the sucrose is unknown but it might be related to the 
primary sequence of the scFv (Takkinen et al. 1991). In 
addition to the primary sequence of the scFv, there are 
some other factors may affect the expression of scFv in 
prokaryotic cells including duration, temperature, 
aeration and gene induction. Each of those factors needs 
to be optimalisized for every scFv, which is time 
consuming when carried out in flask cultures. However, 
a simple optimaliation can be carried out in using a 
fermentor by sequential simplex optimization method 
(Intachai et al. 2015).  
CONCLUSION 
A scFv-monoclonal antibody recognizing 
nucleoprotein of influenza virus was isolated by 
panning a commercial-influenza-A- focused- scFv 
library. Panning with the alternating H1N1 NP and 
H5N1 virion, and elution with H5N1 antiserum assure 
the isolated mAb recognizes multiple, if not all, subtype 
of influenza-A viruses. The anti NP-scFv antibody was 
purified to homogeneity using an affinity 
chromatography. Rabbits immunized with this purified 
NP-scFv produced specific antibody that recognized 
NP-scFv even in a very low concentration in 
immunoassays. The immunoassays carried out in this 
study suggest that the NP-scFv mAb and the rabbit anti 
NP-scFv can be use in developing point-of-care 
diagnostic tools for Avian Influenza.  
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